Cytodyn Inc (CYDY)

[finesand]

10-Q reflection: PO + Delay

No cash left, the usual raise, no surprise,
hopefully at $0.75/sh again.

The real bad: Stretching the timeline again.
2017 March presentation already delayed program 1Q17 -> 2Q17 etc.
Now they say that Combo enrollment is complete 2Q17, where it was expected to have the results!
Further more, Mono enrollment is now expected to be completed 4Q17 where the Combo trial requires the 100pt of the Mono trial for safety. They don't even mention the 100pt enrollment and their safety data, but only say some patients were enrolled in Dec 2016 already. For me, that is the real bummer and could delay the whole combo trial results towards 4Q17, if not later.

EDIT: Since they were just mostly enrolling, I also have to ask how they burned the $2.17M per month?

Thoughts?